Table 3.
CLDQ-NAFLD index by country and fibrosis stagea.
| Country | NASH disease stage |
Overall | |
|---|---|---|---|
| Early (F0–F2) | Advanced (F3–F4) | ||
| France, n | 91 | 28 | 119 |
| Mean (SD) | 5.7 (0.9) | 5.7 (0.7) | 5.7 (0.8) |
| Germany, n | 94 | 36 | 130 |
| Mean (SD) | 5.0 (1.1) | 4.2 (1) | 4.8 (1.1) |
| Italy, n | 152 | 53 | 205 |
| Mean (SD) | 5.1 (1) | 3.7 (1.5) | 4.7 (1.3) |
| Spain, n | 116 | 44 | 160 |
| Mean (SD) | 5.2 (1.2) | 4.6 (1.4) | 5.1 (1.3) |
| USA, n | 55 | 36 | 91 |
| Mean (SD) | 4.7 (1.05) | 4.0 (1.12) | 4.4 (1.12) |
| All, n | 513 | 210 | 723 |
| Mean (SD) | 5.2 (1.1) | 4.4 (1.4) | 4.9 (1.2) |
CLDQ-NAFLD, Chronic Liver Disease Questionnaire – Non-Alcoholic Fatty Liver Disease; NASH, non-alcoholic steatohepatitis.
a
UK data (n = 20) were not used for this question because of a low response rate.